The largest database of trusted experimental protocols

Ms safe protease and phosphatase inhibitor cocktail

Manufactured by Merck Group
Sourced in Sao Tome and Principe, United States

The MS-SAFE Protease and Phosphatase Inhibitor Cocktail is a versatile solution designed to prevent the degradation of proteins and the dephosphorylation of phosphoproteins during sample preparation for mass spectrometry analysis. It contains a combination of protease and phosphatase inhibitors that work to stabilize and preserve the integrity of the sample, ensuring accurate and reliable results.

Automatically generated - may contain errors

7 protocols using ms safe protease and phosphatase inhibitor cocktail

1

Cytoskeletal Protein Fractionation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytoskeletal isolation was performed using the method of Herrmann et al., with the modification of using a mass spectrometry-compatible MS-SAFE Protease and Phosphatase Inhibitor Cocktail (Sigma-Aldrich, St. Louis, MO, United States) [41 (link),42 (link),43 (link)]. This yielded four subcellular fractions: membrane bound/soluble protein (fraction 1); cytoskeletal (fraction 2); high salt-soluble supernatant (fraction 3) and the insoluble cytoskeleton (fraction 4). Fraction 4 was dissolved in 10 M urea. Although fractions 2 and 4 contained the insoluble proteins, fraction 4 was the fraction of choice for the analysis of intermediate filament proteins, as the levels of other non-specific species were significantly reduced [42 (link),43 (link)].
+ Open protocol
+ Expand
2

Proteomic Analysis of Worm Stress Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately 3000 worms per condition were lysed in PBS. A cocktail of protease inhibitor was added to the lysate (Sigma MS-SAFE Protease and Phosphatase Inhibitor Cocktail). Anti-tubulin (Monoclonal anti-alpha-Tubulin antibody produced in mouse, Sigma, T6074) was used for detection of constitutively expressed tubulin for normalization of protein concentrations. HSF1 antibody was procured from Veena Prahlad (Iowa), HSP90 (rabbit anti-DAF-21) from Patricia Van Oosten-Hawle (Leeds), HSP40 (anti-DNJ-12, DNJ-13, and DNJ-19, all raised in rabbits) from Janine Kirstein (Berlin), HSP70 from John Labbadia (UCL, London). Mouse and rabbit secondary antibodies were used (Alexa Fluor 488-conjugated secondary antibodies). All quantifications were performed using ImageJ software to determine the protein band intensity using densitometry. 3-4 technical replicates were used per condition and statistics were performed using the two-way ANOVA against the untreated wild type (N2) and treated Aβ42 (GMC) worms groups. All statistics were performed using GraphPad Prism.
+ Open protocol
+ Expand
3

Immunoblotting for Phosphorylated STAT3

Check if the same lab product or an alternative is used in the 5 most similar protocols
V-SVZ tissue was lysed in radioimmunoprecipitation buffer containing 1× MS-Safe protease and phosphatase inhibitor cocktail (Sigma). Total protein (30 μg) was resolved using 4%–15% gradient Mini-PROTEAN TGX gels (Bio-Rad) according to the manufacturer's protocol, was transferred to nitrocellulose membranes, blocked in 5% BSA (GE Healthcare) and incubated with rabbit anti-p-STAT3 (Tyr705, Cell Signaling Technology, 1:1,000, catalog no. 9145) and mouse anti-STAT3 (Cell Signaling Technology, 1:1,000, catalog no. 9139). Signal was detected using horseradish peroxidase-conjugated secondary antibodies (GE Healthcare), followed by chemiluminescence detection with Amersham ECL substrate (GE Healthcare) and the MicroChemi4.2 system (DNR Bio-Imaging Systems).
+ Open protocol
+ Expand
4

Brain Protein Extraction for p70S6 Kinase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Briefly, crushed frozen brains were added to a lysis buffer containing 20 mM MOPS, 5 mM EGTA, 2 mM EDTA, 1% NP40, 1 mM dithiothreitol, 1 mM benzamidine, 1 mM PMSF, and 10 μg/mL leupeptin/aprotinin, 50 mM β-glycerolphosphate, 50 mM sodium fluoride, and 1 mM sodium vanadate. Benzamidine, leupeptin/aprotinin, β-glycerolphosphate, sodium fluoride, and sodium vanadate were supplied via the reconstitution of a lyophilized powder (i.e. MS-SAFE Protease and Phosphatase Inhibitor Cocktail [Sigma-Aldrich]). Samples were homogenized three times on ice for 20, 10, and 10 seconds, then sonicated for 10 seconds on ice. Samples were subsequently centrifuged at 15,000xg for 30 minutes at 4°C. Protein concentration in the supernatant was determined using the Pierce BCA Protein Assay (Life Technologies) and an equal concentration of protein from each sample was used for the assay. The p70S6 kinase activity assay was carried out according to the manufacturer’s instructions (Enzo Life Sciences, ADI-EKS-470).
+ Open protocol
+ Expand
5

MHC Tetramer and Anti-CD3 Stimulation of J.OT1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The stimulation method of J.OT1 cells is based on a previously established study21 (link). For each replicate per condition, 15 million J.OT1 cells were washed and resuspended in serum-free RPMI at a concentration of 50 million cells per mL. Cells were then incubated with either 10 nM of H-2Kb MHC tetramer (Class I, human beta-2-microglobulin) or ~1 ug/mL of anti-CD3 IgM antibody C305 on ice for 1 h. C305 was diluted in Dulbecco’s phosphate-buffered saline (DPBS) prior to stimulation. MHC tetramers30 (link) were synthesized by the NIH Tetramer Core Facility (Atlanta, GA) using custom peptides from GenScript. The peptide sequences are SIINFEKL (OVA), SIITFEKL (T4), SIIGFEKL (G4), and RGYVYQGL (VSV). Stimulation was initiated by transferring the cells from ice to 37°C. After 3 mins of stimulation at 37°C, cells were lysed with equal volume of lysis buffer (pH 7.6) containing 1% (w/v) sodium dodecyl sulfate (SDS), 100 mM Tris-HCl and 1X MS-SAFE Protease and Phosphatase Inhibitor cocktail (Sigma-Aldrich MSSAFE). PV treatment was performed by incubating J.OT1 cells with 500 μM PV (prepared by mixing equal volume of 1 mM sodium orthovanadate and 1 mM hydrogen peroxide) for 10 minutes at 37°C and lysed with the lysis buffer as mentioned.
+ Open protocol
+ Expand
6

Western Blot Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For western blot analysis, the cells were washed with cold PBS and lysed in a lysis buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.25 mM EDTA (pH 8.0), 0.1% SDS, 1% Triton X-100 and 50 mM NaF, supplemented with MS-SAFE™ Protease and Phosphatase Inhibitor Cocktail (1:100; Sigma-Aldrich, St. Louis, MO, USA) and phosphatase inhibitors (Sigma-Aldrich). The protein concentrations were determined using an Enhanced Bicinchoninic Acid Protein Assay kit (Beyotime Institute of Biotechnology). The cell lysates were mixed with loading buffer (Beyotime Institute of Biotechnology), separated using 12% SDS-PAGE gels and transferred onto a PVDF membrane (EMD Millipore, Billerica, MA, USA). The membranes were subsequently probed with various primary antibodies, appropriate secondary antibodies [goat anti-mouse IgG-horseradish peroxidase (HRP; sc-2005), goat anti-rabbit IgG-HRP (sc-2004) and donkey anti-goat IgG-HRP (sc-2020)] and visualized using enhanced chemiluminescence detection reagents (DNR Bio-Imaging Systems, Ltd., Jerusalem, Israel). The density of the protein bands were assessed using Totallab analysis software, version 2.01 (Nonlinear USA, Inc., Durham, NC, USA).
+ Open protocol
+ Expand
7

Activation of J.OT1 cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The stimulation method of J.OT1 cells is based on a previously established study 21 . For each replicate per condition, 15 million J.OT1 cells were washed and resuspended in serum-free RPMI at a concentration of 50 million cells per mL. Cells were then incubated with either 10 nM of H-2K b MHC tetramer (Class I, human beta-2-microglobulin) or ~1 ug/mL of anti-CD3 IgM antibody C305 on ice for 1 h. C305 was diluted in Dulbecco's phosphate-buffered saline (DPBS) prior to stimulation. MHC tetramers 29 were synthesized by the NIH Tetramer Core Facility (Atlanta, GA) using custom peptides from GenScript. The peptide sequences are SIINFEKL (OVA), SIITFEKL (T4), SIIGFEKL (G4), and RGYVYQGL (VSV). Stimulation was initiated by transferring the cells from ice to 37°C. After 3 mins of stimulation at 37°C, cells were lysed with equal volume of lysis buffer (pH 7.6) containing 1% (w/v) sodium dodecyl sulfate (SDS), 100 mM Tris-HCl and 1X MS-SAFE Protease and Phosphatase Inhibitor cocktail (Sigma-Aldrich MSSAFE). PV treatment was performed by incubating J.OT1 cells with 500 µM PV (prepared by mixing equal volume of 1 mM sodium orthovanadate and 1 mM hydrogen peroxide) for 10 minutes at 37°C and lysed with the lysis buffer as mentioned.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!